01. Nānā Hōʻikeʻike
Ma ʻOkakopa 8, ua hoʻomaka ka 2024 CPHI Worldwide Pharmaceutical Exhibition ma Milan. ʻO ia kekahi o nā hanana makahiki koʻikoʻi i ka ʻoihana lāʻau lapaʻau honua, ua huki ʻia i nā poʻe mai 166 mau ʻāina a me nā wahi. Me nā mea hōʻikeʻike 2,400 a me 62,000 poʻe loea, ua uhi ka hōʻike i 160,000 mau mika square. I ka wā o ka hanana, ua mālama ʻia ma mua o 100 mau ʻaha kūkā a me nā ʻaha kūkā, e kamaʻilio ana i nā kumuhana like ʻole mai nā hoʻoponopono lāʻau lapaʻau a me ka hoʻomohala ʻana i ka lāʻau hou i ka biopharmaceuticals a me ka hoʻomohala hoʻomau.
02. JYMed's Highlights
ʻO Shenzhen JYMed Technology Co., Ltd. (ma hope aku i kapa ʻia ʻo "JYMed"), ʻo ia kekahi o nā mea hana peptide nui loa ma Kina, i hōʻike i nā ʻenehana hou, nā huahana, a me nā manawa hui pū i nā mea kūʻai aku honua ma ka hōʻikeʻike Milan. I ka wā o ka hanana, ua komo ka hui JYMed i nā kūkākūkā hohonu me nā hui lāʻau lapaʻau a me nā mea kūʻai mai a puni ka honua, kaʻana like i nā ʻike e pili ana i nā pilikia koʻikoʻi o ka ʻoihana peptide a hāʻawi i nā manaʻo a me nā ʻōlelo paipai no ka hoʻomohala ʻana o ka ʻoihana.
Hāʻawi ʻo JYMed i kahi kahua honua no ka noiʻi ʻana a me ka hana ʻana i nā peptides, nā pūhui peptide-like, a me nā conjugates peptide-drug (PDCs). Paʻa ka ʻoihana i ka ʻike i ka synthesis peptide paʻakikī, kemika peptide kumu, a me nā ʻenehana hana nui. Ua hoʻokumu ʻo ia i nā hui hoʻolālā lōʻihi me nā ʻoihana kaulana honua. Manaʻo ʻo JYMed ma o ke kaʻana like ʻana i nā kumuwaiwai a me nā ikaika hoʻohui, hiki iā ia ke lawe mai i ka manaʻolana a me nā koho i nā poʻe maʻi ma ka honua holoʻokoʻa.
03. Hōʻike hōʻuluʻulu manaʻo
E alakaʻi ʻia ana e ka philosophy o "Peptides for a Better Future," e hoʻomau ʻo JYMed i ka hoʻokele ʻana i ka lāʻau lapaʻau a hāʻawi i ke olakino a me ka maikaʻi o nā maʻi a puni ka honua. Ke kakali nei mākou i ka hana pū me nā hoa pili honua e apo i ka wā e hiki mai ana no ka ʻoihana lāʻau lapaʻau.
E pili ana iā JYMed
Ua hoʻokumu ʻia ʻo Shenzhen JYMed Technology Co., Ltd. (ma hope aku i kapa ʻia ʻo JYMed) i ka makahiki 2009, ʻoihana loea i ka noiʻi, hoʻomohala, hana, a kūʻai aku i nā peptides a me nā huahana pili i ka peptide. Me hoʻokahi kikowaena noiʻi a me ʻekolu kumu hana nui, ʻo JYMed kekahi o nā mea hana nui loa o nā peptide chemically synthesized API ma Kina. Ua hoʻokiʻekiʻe ka hui R&D koʻikoʻi o ka hui ma mua o 20 mau makahiki o ka ʻike ma ka ʻoihana peptide a ua lanakila ʻelua i ka nānā ʻana o FDA. Hāʻawi ka ʻōnaehana peptide industrialization a JYMed i nā mea kūʻai aku i nā lawelawe holoʻokoʻa, me ka hoʻomohala ʻana a me ka hana ʻana o nā peptides therapeutic, nā peptides holoholona, nā peptides antimicrobial, a me nā peptides cosmetic, a me ke kākau inoa ʻana a me ke kākoʻo hoʻoponopono.
Nā Hana Hana Nui
1. Hoʻopaʻa inoa kūloko a me ka honua o nā API peptide
2. Nā peptides holoholona a me nā mea hoʻonaninani
3. Nā peptides maʻamau a me nā lawelawe CRO, CMO, OEM
4. Nā lāʻau PDC (peptide-radionuclide, peptide-liʻiliʻi mole, peptide-protein, peptide-RNA)
Ma kahi o Tirzepatide, ua hoʻouna ʻo JYMed i nā palapala hoʻopaʻa inoa me ka FDA a me CDE no nā huahana API ʻē aʻe, me nā lāʻau lapaʻau GLP-1RA kaulana i kēia manawa e like me Semaglutide a me Liraglutide. Hiki i nā mea kūʻai aku e hoʻohana ana i nā huahana a JYMed ke kuhikuhi pololei i ka helu hoʻopaʻa inoa CDE a i ʻole ka helu faila DMF i ka wā e hoʻouna ana i nā noi hoʻopaʻa inoa i ka FDA a i ʻole CDE. E hōʻemi nui kēia i ka manawa e pono ai no ka hoʻomākaukau ʻana i nā palapala noi, a me ka manawa loiloi a me ke kumukūʻai o ka loiloi huahana.
Kāhea iā mā˚ou
Shenzhen JYMed Technology Co., Ltd.
Helu helu:8th & 9th Floors, Building 1, Shenzhen Biomedical Innovation Industrial Park, No. 14 Jinhui Road, Kengzi Subdistrict, Pingshan District, Shenzhen
Kelepona:+86 755-26612112
Pūnaewele: http://www.jymedtech.com/
Ka manawa hoʻouna: Oct-18-2024